New Jersey · 2026-2027 Regular Session · Bill

A 5784: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Introduced

Plain-language summary

A 5784 is a bill introduced in the New Jersey House. According to its official title, it concerns: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product. Primary sponsor: Roy Freiman (Democratic).

Sponsors

Primary sponsor: Roy Freiman (Democratic).